AsitParikhMD

Gastroenterology • Boston, MA

Physician

Join to view full profile

Dr. Parikh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Parikh's full profile

Already have an account?

Office
55 Fruit Street
Blk 4
Boston, MA 02114
Phone+1 617-724-6113

Fax+1 617-724-6832

Education & Training

Massachusetts General HospitalFellowship, Gastroenterology, 2002 - 2005
University of Pennsylvania Health SystemResidency, Internal Medicine, 2000 - 2002
Vanderbilt University School of MedicineClass of 2000

Certifications & Licensure

MA State Medical License 2002 - 2025
PA State Medical License 2001 - 2002

Publications & Presentations

PubMed

134 citations
Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results
Tim Wyant, Timothy Leach, Serap Sankoh, Yuemei Wang, Jonathan Paolino
Gut. 2015-01-01
507 citations
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
Bruce E. Sands, Brian G. Feagan, Paul Rutgeerts, Jean-Frederic Colombel, William J. Sandborn
Gastroenterology. 2014-09-01
28 citations
Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease.
Maria Rosario, Jonathan L French, Nathanael L Dirks, Serap Sankoh, Asit Parikh
Journal of Crohn's & Colitis. 2017-08-01

Press Mentions

MOMA Therapeutics Appoints Hans Bitter, Ph.D., as Senior Vice President and Head, Data ScienceOctober 5th, 2021
Flagship Keeps Ex-FDA Commish Stephen Hahn Busy with Another CMO Gig; Daphne Koller Makes Key Hire at Insitro by Welcoming Google and Facebook VetSeptember 10th, 2021
MOMA Therapeutics Appoints Semi Trotto as Chief People and Experience OfficerSeptember 8th, 2021
Join now to see all

Other Languages

French, Hindi, Gujarati